Stock PCSA PROCESSA PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Processa Pharmaceuticals, Inc.

Equities

PCSA

US74275C3043

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-01 pm EDT 		5-day change 1st Jan Change
2.22 USD +1.83% Intraday chart for Processa Pharmaceuticals, Inc. +37.04% -66.83%
Apr. 30 Processa Pharmaceuticals, Inc. Names Steven Cha as Senior Vice President of Clinical Research CI
Apr. 30 Certain Common Warrants of Processa Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 30-APR-2024. CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Processa Pharmaceuticals, Inc. Names Steven Cha as Senior Vice President of Clinical Research
CI
Processa Pharmaceuticals, Inc. Mourns the Sudden Passing of Board Member Virgil Thompson
CI
Processa Pharmaceuticals Names George Ng as CEO
MT
Processa Pharmaceuticals, Inc. Appoints George Ng as Chief Executive Officer
CI
Processa Pharmaceuticals, Inc. Announces Board Changes
CI
Processa Pharmaceuticals, Inc. Elects Khoso Baluch as Director
CI
Khalid Islam Not to Stand for Re-Election as Director of Processa Pharmaceuticals, Inc
CI
Processa Pharmaceuticals, Inc. Announces Executive Changes
CI
Processa Pharmaceuticals, Inc. Appoints R. Michael Floyd as Chief Operating Officer
CI
Processa Pharmaceuticals, Inc Appoints John Devane and James Shipley to its Medical and Scientific Advisory Board
CI
Processa Pharmaceuticals, Inc. Appoints Geraldine Pannu to the Board of Directors
CI
Processa Pharmaceuticals, Inc. Appoints James Stanker as Chief Financial Officer
CI
Heatwurx Inc. will Change its Name to Processa Pharmaceuticals, Inc
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PCSA Stock
  4. News Processa Pharmaceuticals, Inc.
  5. Insiders